ARTV earnings: real EPS beat/miss history, analyst consensus Buy, P/E -2.82. Updated 2026-07-23.
Artiva Biotherapeutics (ARTV) Research Hub
Artiva Biotherapeutics (ARTV) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 10.22 USD (-5.28%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.82, market cap 0.24B. This hub links to the full technical, earnings and options research available for ARTV.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 10.22 USD (-5.28%) |
| 52-week range | 8.52 USD – 12.27 USD |
| Trend regime | Range |
| 14-day RSI | 39.8 (Bearish) |
| Trailing P/E | -2.82 |
| Market cap | 0.24B |
| Dividend yield | 0.00% |
Available research for ARTV
Covered Call on ARTV: how it works, illustrative setup around the real 10.22 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ARTV: how it works, illustrative setup around the real 10.22 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ARTV: how it works, illustrative setup around the real 10.22 USD price, max profit/loss, breakeven and when to use it. Educational.
ARTV technical analysis: range, last 10.22 USD, RSI 39.8, 52w range 8.52 USD–12.27 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ARTV in?
Artiva Biotherapeutics (ARTV) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ARTV in an uptrend or downtrend?
As of 2026-09-11, ARTV is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ARTV's trailing P/E ratio?
ARTV's trailing P/E is -2.82, with a market cap of 0.24B. See the earnings research page for full valuation detail.